Rating Change
Argus Research reiterated its Buy rating on Cardinal Health, Inc. (NYSE:CAH) on November 12, 2026.
reiterateNYSE:CAH
Argus Research Reiterates Buy Rating on Cardinal Health, Inc. (CAH)
Argus Research reiterated its Buy rating on Cardinal Health, Inc. (NYSE:CAH) on November 12, 2026.
At publication ·
What changed
Cardinal Health, Inc. (NYSE:CAH) · reiterate
- Firm
- Argus Research
- Rating
- Buy to Buy
- Price at event
- $278.14
- Market capitalization
- $47.1B
At a glance
Key takeaways
- Argus Research maintained a Buy rating on Cardinal Health (CAH) on November 12, 2026, with the stock trading at $278.14.
- Cardinal Health has gained 36.7% over the past 52 weeks and has a market capitalization of $47.1 billion.
- Among the 10 most recent analyst ratings, 8 are Buy, 2 are Hold, and 0 are Sell, showing broad analyst support.
- Analyst ratings and price targets are one input among many for investment decisions, and their predictive power varies.
Market Context
Cardinal Health, Inc. operates in the Healthcare sector. The stock currently trades at $278.14 with a market capitalization of $47.1B. The stock has gained 36.7% over the past 52 weeks.
Analyst coverage from Argus Research provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Cardinal Health, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Cardinal Health, Inc.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Nov 12, 2026 | Argus Research | Buy | N/A |
| Nov 10, 2026 | JP Morgan | Neutral | N/A |
| Nov 09, 2026 | TD Cowen | Buy | N/A |
| Nov 06, 2026 | RBC Capital | Outperform | N/A |
| Nov 06, 2026 | Evercore ISI Group | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View CAH Stock Page
Frequently Asked Questions
What does the Buy rating mean for CAH?
A rating of Buy from Argus Research reflects the analyst's outlook on Cardinal Health, Inc. (NYSE:CAH). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CAH forecast page.
Loading related coverage…
